Leading in the Conquest of Cancer
The following statistics help illustrate what sets the U-M Cancer Center's faculty, staff and programs apart as Leaders and Best™ in cancer. But numbers can tell only part of the story. Click on any link below to read the stories behind the numbers.
The company we keep
- The U-M Cancer Center is one of only 41 centers in the United States to earn the National Cancer Institute's "comprehensive" designation. This, the highest designation in the understanding and treatment of cancer, confirms our commitment to outstanding clinical care, wide-ranging research initiatives, education, outreach and the training of tomorrow's cancer experts.
- The Cancer Center is also a founding member of the National Comprehensive Cancer Network, a consortium of 25 of the nation's premier centers, which develops national guidelines for the delivery of effective, quality care.
- Among more than 900 hospitals considered, the University of Michigan ranks 34th on the U.S. News list of best hospitals for cancer - Michigan ranks highest among institutions in the Midwest, and is the only hospital in the state to rank in the top 50.
Confidence that comes with experience
Ours is among the largest clinical enterprises in cancer. Patients meet with multidisciplinary teams in one of 17 multidisciplinary and 10 specialty clinics, organized by cancer type.
Here's a snapshot of our 2013/2014 clinical activities:
- 97,147 outpatient visits
- 58,419 infusion treatments
- 4,590 radiation consults
- 3,498 cancer patients discharged from university hospitals
These numbers mean our patients benefit from having experienced, knowledgeable doctors, nurses and other clinical experts involved in diagnosing and treating every patient's case, from the most common to the rarest and most complex.
The top 5 cancers diagnosed and treated at the University of Michigan:
U-M has been recognized by the national Blue Cross Blue Shield Association as a Blue Distinction Center for Complex and Rare Cancers® for our work within 13 Cancer Center programs:
- Acute Leukemia - Inpatient, Non-Surgical
- Bone - Primary
- Brain - Primary
- Head and Neck
- Liver - Primary
- Ocular Melanoma
- Soft Tissue Sarcomas
- Thyroid - Medullary and/or Anaplastic
Putting Patients and Families First
Our commitment to the conquest of cancer is surpassed only by our commitment to treating patients like members of our own family. How are we doing?
Our Cancer Center Patient Satisfaction statistics confirm that we excel - and continue to improve - in caring for patients and families:
- 2004 = 88%
- 2006 = 89%
- 2008 = 90%
- 2010 = 90%
- 2012 = 92%
- 2013 = 95%
Because we understand the impact cancer has on every life it touches, we invest in staff and programs to reduce the burden of cancer for patients and those who love them:
- Our Patient and Family Support Services (PFSS) Program currently offers more than 30 programs and services led by specialists in psychology, social work, art therapy, nutrition, finance, and other areas. In 2013, more people than ever before took advantage of one or more PFSS offerings
- Staffed by registered oncology nurses with more than 105 years of combined experience, the U-M Cancer AnswerLine™ provides toll-free access to personalized information on the entire spectrum of cancer issues, helping individuals navigate the complexities of the health care system and connect with support groups and community resources. In fiscal year 2013, the Cancer AnswerLine™ responded to 4,983 inquiries.
Research: more insights, more options
The U-M Comprehensive Cancer Center consistently ranks in the top 10 nationally in grant funding from the National Cancer Institute. Our medical school currently ranks first on that list.
Michigan receives more than $188 million in grants annually from the NCI and other agencies.
More than 365 U-M faculty members provide care to cancer patients and collaborate on laboratory, clinical, prevention and outcomes research.
Michigan is home to 3 Specialized Programs of Research Excellence (SPORE), in head and neck, prostate and gastrointestinal cancers. These significant, multi-year NCI research grants focus on prevention, early detection, diagnosis and treatment of a specific cancer type. In addition, as a member of the Sarcoma Alliance for Research through Collaboration (SARC), the Cancer Center's Sarcoma Program plays a pivotal role in one of only two SPORE grants focused on sarcoma.
Our patients are the most important beneficiaries of Michigan's vigorous commitment to research. Through more than 358 active cancer-related clinical trials, patients have access to the very latest treatment advances, often before they are available in the community.
Serving our community and yours
In 2013 the Cancer Center participated in more than 75 community events in Ann Arbor and statewide.
We maintain a speaker's bureau of experts available to participate in local educational and outreach events.
Print our 2013 Highlights brochure [pdf].